Related Experiment Video

Updated: Sep 24, 2025

Utility of Dissociated Intrinsic Hand Muscle Atrophy in the Diagnosis of Amyotrophic Lateral Sclerosis
08:16

Utility of Dissociated Intrinsic Hand Muscle Atrophy in the Diagnosis of Amyotrophic Lateral Sclerosis

Published on: March 4, 2014

32.4K

Correction to: Comparative All-Cause Mortality Among a Large Population of Patients with Spinal Muscular Atrophy

Emma Viscidi1, Maneesh Juneja2, Jin Wang3

  • 1Biogen, 225 Binney Street, Cambridge, MA, 02142, USA. emma.viscidi@biogen.com.

Neurology and Therapy
|May 4, 2022
PubMed
Abstract

No abstract available in PubMed .

More Related Videos

Measurements of Motor Function and Other Clinical Outcome Parameters in Ambulant Children with Duchenne Muscular Dystrophy
09:18

Measurements of Motor Function and Other Clinical Outcome Parameters in Ambulant Children with Duchenne Muscular Dystrophy

Published on: January 12, 2019

10.5K
Behavioral and Locomotor Measurements Using an Open Field Activity Monitoring System for Skeletal Muscle Diseases
06:52

Behavioral and Locomotor Measurements Using an Open Field Activity Monitoring System for Skeletal Muscle Diseases

Published on: September 29, 2014

54.0K

Related Experiment Videos

Last Updated: Sep 24, 2025

Utility of Dissociated Intrinsic Hand Muscle Atrophy in the Diagnosis of Amyotrophic Lateral Sclerosis
08:16

Utility of Dissociated Intrinsic Hand Muscle Atrophy in the Diagnosis of Amyotrophic Lateral Sclerosis

Published on: March 4, 2014

32.4K
Measurements of Motor Function and Other Clinical Outcome Parameters in Ambulant Children with Duchenne Muscular Dystrophy
09:18

Measurements of Motor Function and Other Clinical Outcome Parameters in Ambulant Children with Duchenne Muscular Dystrophy

Published on: January 12, 2019

10.5K
Behavioral and Locomotor Measurements Using an Open Field Activity Monitoring System for Skeletal Muscle Diseases
06:52

Behavioral and Locomotor Measurements Using an Open Field Activity Monitoring System for Skeletal Muscle Diseases

Published on: September 29, 2014

54.0K

Related Concept Videos

Comparing the Survival Analysis of Two or More Groups01:20

Comparing the Survival Analysis of Two or More Groups

309
Survival analysis is a cornerstone of medical research, used to evaluate the time until an event of interest occurs, such as death, disease recurrence, or recovery. Unlike standard statistical methods, survival analysis is particularly adept at handling censored data—instances where the event has not occurred for some participants by the end of the study or remains unobserved. To address these unique challenges, specialized techniques like the Kaplan-Meier estimator, log-rank test, and...
309

Articles linked to this work by shared authors, journal, and citation graph.

Herpes zoster frequency and severity in immunocompromised pediatric populations: a structured narrative review.

Frontiers in pediatrics·2026

A narrative review of COVID-19 epidemiology and mRNA vaccine impact in children <12 years during the omicron era (November 2021 - December 2025).

Expert review of vaccines·2026

Projecting the population-level impact of norovirus vaccines.

Epidemics·2025

A narrative review of norovirus epidemiology, biology, and challenges to vaccine development.

NPJ vaccines·2024

Incidence of Herpes Zoster and Postherpetic Neuralgia and Herpes Zoster Vaccination Uptake in a US Administrative Claims Database.

Open forum infectious diseases·2024

A Post-Marketing Surveillance Study of Nusinersen for Spinal Muscular Atrophy in Routine Medical Practice in China: Interim Results.

Advances in therapy·2024

After the Spasms: Long-Term Outcomes Following Pulsatile Dexamethasone Therapy for Infantile Epileptic Spasms Syndrome: A Retrospective Observational Study.

Neurology and therapy·2026

Three-Year Follow-Up of Delandistrogene Moxeparvovec in Duchenne Muscular Dystrophy: Long-Term Phase 3 EMBARK Trial Results.

Neurology and therapy·2026

Evaluating Bioequivalence of a New, Higher-Concentration Diazepam Nasal Spray for Seizure Clusters Compared with the Current Formulation in Healthy Adults.

Neurology and therapy·2026

Current and Emerging Therapies for Generalized Myasthenia Gravis: Toward Precision Medicine.

Neurology and therapy·2026

Clobazam Use in Epilepsy: An Old Story with a New Twist. A Narrative Review.

Neurology and therapy·2026

Cerebrospinal Fluid Biomarker Ratio Concordance with Amyloid Positron-Emission Tomography: A Diagnostic Test Accuracy Meta-analysis.

Neurology and therapy·2026

Loneliness as a pathway linking hearing decline to cognitive aging: Longitudinal and genetic evidence.

Alzheimer's & dementia : the journal of the Alzheimer's Association·2026

Vitality as a Prognostic Biomarker in Hematologic Malignancies: Association With Overall Survival and Progression-Free Survival.

Cureus·2026

9-1-1, what is your emergency? Human-centered artificial intelligence, language access and health policy.

Health affairs scholar·2026

Quality of life after open descending thoracic and thoracoabdominal aortic repair: A prospective cohort study.

JTCVS open·2026

Postoperative changes in QRS duration and long-term mortality after septal myectomy.

JTCVS open·2026

Nonlinear association between perceived social support and fear of disease progression in stroke patients: a cross-sectional study.

Frontiers in public health·2026
See all related articles
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies
Jove
Visualize
Contact Us